ArticleCell reports. Physical science2026
Matrix degradation promotes fibronectin deposition and spatial remodeling in 3D.
Article in Cell reports. Physical science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
The extracellular matrix (ECM) coordinates the interplay between biochemical and biophysical cues to regulate cell behavior, yet isolating their individual contributions remains difficult as they are interdependent in native tissues. Here, we present a modular hydrogel platform that independently controls growth factor delivery and user-defined enzymatic matrix degradation. We show that matrix degradation alone, in the absence of exogenous growth factors, is sufficient to drive cell spreading, migration, and fibronectin deposition and assembly. Growth factor stimulation enhanced spheroid expansion but did not induce organized fibronectin remodeling unless combined with matrix degradation. Mechanistic inhibitor studies revealed that degradation-enabled fibronectin remodeling is primarily contractility dependent and MMP independent. These results support a feedback model wherein matrix degradation creates a permissive microenvironment for cell migration and fibronectin deposition, reinforcing focal adhesion formation, cell contractility, and further ECM assembly. This work identifies matrix degradation as an instructive regulator of fibronectin deposition, assembly, and remodeling, offering a framework for designing dynamic hydrogels that emulate tissue remodeling during development and healing.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.